By leveraging our production facilities we've supported the global supply of vaccines and therapeutics. Novartis has partnered with multistakeholder consortia, including the COVID-19 Therapeutics Accelerator, coordinated by the Bill & Melinda Gates Foundation, the Wellcome Trust and Master-card, as well as a partnership supported by the Innovative Medicines Initiative.